$ALAB

Astera Labs (ALAB) Q2 2024 Earnings: Results, Market Reaction & History

Astera Labs (ALAB) reported Q2 2024 earnings with strong revenue growth, expecting $95M-$100M in Q3, up 24-30%. GAAP gross margin is 75%, with a diluted loss per share of $0.06-$0.08. Non-GAAP EPS is projected at $0.16-$0.17. Growth is driven by AI platform production at hyperscalers, according to the company.

Original reporting
Published Sep 1, 2026, 11:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 11:45 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Astera Labs (ALAB) Q2 2024 Earnings: Results, Market Reaction & History — source image
Decision brief

The 30-second read

$ALABBullishMed
01

Why it matters

The guidance suggests continued top‑line momentum but GAAP losses persist, shaping short‑term price expectations.

02

Market read

Guidance updates are material for traders tracking AI‑related hardware stocks.

03

What to watch

Potential supply‑chain constraints and competition from larger chipmakers could pressure margins.

Relevance 7/10Novelty 7/10Timing: post‑earnings guidance release

Background

Astera Labs reported Q2 results and provided forward guidance for Q3 FY2024.

Company-level read

Ticker impact

$ALABBullishMedium confidence
Context

Astera Labs disclosed Q3 FY2024 revenue guidance of $95M‑$100M and GAAP loss per share of $0.06‑$0.08.

Expected impact

Potential upside if revenue exceeds the lower end of guidance; downside risk if misses.

Evidence & confidence

Revenue growth of 24‑30% sequentially and high gross margins suggest improving fundamentals, but GAAP loss may limit upside.

Market effects

Positive signal for AI‑related semiconductor sector as Astera ramps production for hyperscalers.

Limited to US-listed semiconductor niche; no broad regional effect.

Modest, may influence investor sentiment toward small‑cap AI hardware suppliers.

Counterpoint

Guidance may be overly optimistic; execution risk at hyperscaler production ramp could lead to missed targets.

Key entities

  • Astera Labs

    US‑listed semiconductor firm (ticker ALAB).

Related articles

$ALABMed

3 Millionaire-Maker Artificial Intelligence (AI) Stocks to Buy Now

Astera Labs (ALAB) reported Q1 2026 revenue of $308.4M, up 93% YoY, with 76.3% gross margin. Credo Technology (CRDO) saw Q2 2026 revenue of $268M, up 272% YoY, and guided for over 200% FY growth. Vertiv (VRT) reported a $15B backlog with a 2.9 book-to-bill ratio in Q4 2025, expanding liquid cooling capacity. All three companies are involved in AI infrastructure.

$NVDAMedAI 8/10

Yuanta Sees NVIDIA MediaTek Deal Strengthening AI Infrastructure Market Reach

Yuanta Securities highlights NVIDIA's expanded partnership with MediaTek, including a $3.5B investment, to strengthen AI infrastructure. MediaTek will join NVIDIA's NVLink Fusion ecosystem, enabling custom XPU designs for data centers, devices, and automotive platforms. Yuanta sees potential benefits for NVIDIA, MediaTek, Marvell, Astera Labs, Broadcom, Synopsys, Cadence, and TSMC.

HighAI 9/10

Astera Labs Stock Soars 116% on Record AI Connectivity Chip Revenue

Astera Labs reported Q2 revenue of $392.4M, up 104% YoY, beating estimates. The company's stock surged 116%, closing at $289.47 with a market cap of $50.22B. Astera's chips, retimers, and switches support AI infrastructure, with record revenue from its Aries and Scorpio product lines. The company guided Q3 revenue to $540M-$560M, with strong profit margins. Analysts have a buy consensus and an average price target of $389.95.

$CRDOMed

3 Under-the-Radar AI Stocks Wall Street Is Missing

Credo Technology (CRDO) reported Q4 2026 revenue of $437M, up 157% YoY, with guidance for 80% YoY growth in 2027. Astera Labs (ALAB) saw Q2 2026 revenue of $392.4M, up 104% YoY, with Scorpio X series ramping ahead of schedule. Camtek (CAMT) reported Q2 2026 revenue of $133.24M, up 8% YoY, with a strong order book extending into 2027.